Cara Therapeutics(CARA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CARA Cara Therapeutics

Not Yet Opened 11-13 16:00:00 EST

0.3241

-0.0169

-4.96%

盘后0.3201

-0.0040-1.23%

19:21 EST

High0.3449	Low0.3240	Vol641.72K
Open0.3310	D1 Closing0.3410	Amplitude6.13%
Mkt Cap17.78M	Tradable Cap15.16M	Total Shares54.85M
T/O209.83K	T/O Rate1.37%	Tradable Shares46.78M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CARA","market":"US","secType":"STK","nameCN":"Cara Therapeutics","latestPrice":0.3241,"timestamp":1731531600000,"preClose":0.341,"halted":0,"volume":641723,"hourTrading":{"tag":"盘后","latestPrice":0.3201,"preClose":0.3241,"latestTime":"19:21 EST","volume":2438,"amount":788.735,"timestamp":1731543696173},"delay":0,"floatShares":46778303,"shares":54846639,"eps":-2.039219,"marketStatus":"Not Yet Opened","change":-0.0169,"latestTime":"11-13 16:00:00 EST","open":0.331,"high":0.3449,"low":0.324,"amount":209828.64853654,"amplitude":0.06129,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.039219,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731574800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":0.341,"preHourTrading":{"tag":"盘前","latestPrice":0.3365,"preClose":0.341,"latestTime":"09:29 EST","volume":659,"amount":220.42380275,"timestamp":1731508199012},"postHourTrading":{"tag":"盘后","latestPrice":0.3201,"preClose":0.3241,"latestTime":"19:21 EST","volume":2438,"amount":788.735,"timestamp":1731543696173},"volumeRatio":0.416061,"impliedVol":1.6901,"impliedVolPercentile":0.4921},"requestUrl":"/m/hq/s/CARA","defaultTab":"news","newsList":[{"id":"2481834574","title":"Cara Therapeutics Inc    expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481834574","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481834574?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:52","pubTimestamp":1731081142,"startTime":"0","endTime":"0","summary":"* Cara Therapeutics Inc     is expected to show a fall in quarterly revenue when it reports  results on November 11 (estimated) for the period ending September 30 2024   * The Stamford Connecticut-bas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cara Therapeutics Inc    expected to post a loss of 25 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA"],"gpt_icon":0},{"id":"2479767277","title":"BRIEF-CSL Limited Reports 13.5% Stake In Cara Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2479767277","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479767277?lang=en_us&edition=fundamental","pubTime":"2024-10-31 06:26","pubTimestamp":1730327216,"startTime":"0","endTime":"0","summary":"Oct 30 (Reuters) -    CSL Limited:   * CSL LIMITED REPORTS 13.5% STAKE IN CARA THERAPEUTICS INC AS OF OCT 23 - SEC FILINGSource text:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA","LU1169590202.USD","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","LU0728928796.USD","BK4007","CSL","BK4086"],"gpt_icon":0},{"id":"2479507997","title":"CSL Limited Reports 13.5% Stake in Cara Therapeutics Inc as of Oct 23 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2479507997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479507997?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:23","pubTimestamp":1730319800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARA","BK4007"],"gpt_icon":0},{"id":"2472938678","title":"Carasent Expects Relisting To Nasdaq Stockholm To Be Completed In Dec 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2472938678","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472938678?lang=en_us&edition=fundamental","pubTime":"2024-10-04 16:06","pubTimestamp":1728029201,"startTime":"0","endTime":"0","summary":"Carasent ASA :Cross-Border Merger, Relisting To Nasdaq Stockholm Estimated To Be Completed In Dec 2024.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NQmain","BK4585","LU2095319765.USD","LU2210149790.SGD","MNQmain","LU2210150020.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD",".IXIC","QID","QLD","CARA","SQQQ","PSQ","NDAQ","BK4112","IE00B64PRP62.GBP","BK4588","TQQQ","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2460086745","title":"North American Morning Briefing: Stock Rebound Pauses Ahead of Jackson Hole Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2460086745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460086745?lang=en_us&edition=fundamental","pubTime":"2024-08-19 18:15","pubTimestamp":1724062500,"startTime":"0","endTime":"0","summary":"The stock rebound hit pause ahead of a busy week for central bank watchers.Stock futures wavered early on Monday as the Jackson Hole Symposium takes center stage this week.Investors have renewed belief in a soft landing for the economy and scaled-back expectations for aggressive Fed cuts, SEB said.The Nikkei slipped 1.8%, dragged by a sharply stronger yen. Domestic stocks may also have been weighed by possible profit-taking, given the benchmark index's five-session winning streak.EUR/USD rose to a seven-and-a-half-month high and the euro could extend the rise against the dollar if investors trim ECB rate-cut expectations--if the release of second-quarter eurozone negotiated wages data on Tuesday shows wages remain elevated--and U.S. economic data was weaker, ING said.Sterling rose, supported by a weaker dollar but also potentially due to demand from merger and acquisition activity, according to ING.The impact of M&A on foreign exchange is very cloudy as it's unclear what extent a cross","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AWH","EL","ULTA","LU1074936037.SGD","US6M.BOND","US10Y.BOND","BK4585","DMKPQ","DMSL","LYRA","BK4561","CSSE","DWSN","AMD","GRTX","BRK.A","LU1366333091.USD","US912797GW17.BOND","LU0149725797.USD","TIL","US912797HE00.BOND","CFNB","BK4099","US2Y.BOND","US7Y.BOND","AREN","BK4551","CPTN","LU0787776722.HKD","ET","DDD","LU1201861249.SGD","US5Y.BOND","US912797GL51.BOND","IE00B775SV38.USD","IBRX","AISP","XELA","CUE","LU0980610538.SGD","CENN","TRDA","GVP","FACO","AFG","GOSS","LU1363072403.SGD","US3Y.BOND","US30Y.BOND","US12M.BOND","CARA"],"gpt_icon":1},{"id":"2459063264","title":"Cara: Q2 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2459063264","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459063264?lang=en_us&edition=fundamental","pubTime":"2024-08-16 01:55","pubTimestamp":1723744536,"startTime":"0","endTime":"0","summary":"STAMFORD, Conn.  — STAMFORD, Conn.  — Cara Therapeutics Inc.  on Wednesday reported a loss of $20 million in its second quarter.On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 37 cents.The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.The biotechnology company posted revenue of $991,000 in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $1.3 million.The company's shares closed at 34 cents. A year ago, they were trading at $3.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cara-q2-earnings-snapshot-175536183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CARA"],"gpt_icon":0},{"id":"2459954294","title":"Cara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2459954294","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459954294?lang=en_us&edition=fundamental","pubTime":"2024-08-15 12:59","pubTimestamp":1723697945,"startTime":"0","endTime":"0","summary":"* Cara Therapeutics Inc    reported a quarterly adjusted loss of 37 cents per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of -58 cents.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA"],"gpt_icon":0},{"id":"2456098754","title":"Cara Therapeutics Inc    expected to post a loss of 27 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2456098754","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456098754?lang=en_us&edition=fundamental","pubTime":"2024-08-02 19:09","pubTimestamp":1722596988,"startTime":"0","endTime":"0","summary":"* Cara Therapeutics Inc     is expected to show a fall in quarterly revenue when it reports  results on August 5 (estimated) for the period ending January 1 0001   * The Stamford Connecticut-based  co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cara Therapeutics Inc    expected to post a loss of 27 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA"],"gpt_icon":0},{"id":"2452343627","title":"Cara Therapeutics, Inc.'s (NASDAQ:CARA) Price Is Right But Growth Is Lacking After Shares Rocket 34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452343627","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452343627?lang=en_us&edition=fundamental","pubTime":"2024-07-18 19:22","pubTimestamp":1721301722,"startTime":"0","endTime":"0","summary":"Cara Therapeutics, Inc. ( NASDAQ:CARA ) shareholders are no doubt pleased to see that the share price has bounced 34...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cara/cara-therapeutics/news/cara-therapeutics-incs-nasdaqcara-price-is-right-but-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TQQQ","NQmain","LU2210150020.SGD","CARA","BK4007","LU2095319765.USD","BK4585",".IXIC","QID","SQQQ","LU2210149790.SGD","BK4588","BK4112","MNQmain","NDAQ","PSQ","QLD"],"gpt_icon":1},{"id":"2450316488","title":"Cara hires Piper Sandler to help explore strategic alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2450316488","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450316488?lang=en_us&edition=fundamental","pubTime":"2024-07-12 05:12","pubTimestamp":1720732366,"startTime":"0","endTime":"0","summary":"Cara Therapeutics  stock closed 28% higher Thursday after it announced it had hired Piper Sandler as its financial advisor to help it explore strategic options. Cara’s  board has also approved a cash savings plan for the company, which had around $70M in cash and equivalents as of March 31.  The company added that it won’t comment further on its efforts to explore strategic alternatives until its board has approved a specific action or determined such disclosure is appropriate or required by law. Cara  announced last month that it planned to seek out strategic alternatives for the company after its pruritus drug candidate difelikefalin failed in a key clinical trial.","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097298712/image_1097298712.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097298712/image_1097298712.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4123815-cara-hires-piper-sandler-to-help-explore-strategic-alternatives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4007","CARA"],"gpt_icon":0},{"id":"2450955357","title":"Sector Update: Health Care Stocks Advance Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2450955357","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450955357?lang=en_us&edition=fundamental","pubTime":"2024-07-11 21:10","pubTimestamp":1720703401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4588","CSL.AU","PFE.AU","IBB","SG9999002224.SGD","SG9999004303.SGD","BK7095","XLV","LU0289739699.SGD","IE00BLSP4239.USD","BK4585","LU0170899867.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","SG9999001176.SGD","CARA","SG9999011175.SGD","LU0868494617.USD","AKBA","LU1894683348.USD","SG9999013999.USD","BK4550","BK4581","IE00B19Z3B42.SGD","LU0321505868.SGD","LU1169589451.USD","BK4534","LU1883839398.USD","BK4007","FDN","LU0321505439.SGD","LU1894683264.USD","BK4568","SG9999003800.SGD","SGXZ23171101.USD","LU0456855351.SGD","LU1066051498.USD","LU0058720904.USD","BK4592","LU0122379950.USD","LU0234572021.USD","LU1066053197.SGD","SG9999001176.USD","LU1169590202.USD","CSL","SG9999002232.USD","IE00B19Z3581.USD","BK4086","PFE"],"gpt_icon":0},{"id":"2450357145","title":"Sector Update: Health Care Stocks Advance Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450357145?lang=en_us&edition=fundamental","pubTime":"2024-07-11 21:10","pubTimestamp":1720703401,"startTime":"0","endTime":"0","summary":"Health care stocks were advancing premarket Thursday, with the Health Care Select Sector SPDR Fund  marginally higher and the iShares Biotechnology ETF  up 1.1% recently.Pfizer  rose more than 2% after saying it will conduct dose optimization studies of danuglipron in the second half of the year after selecting a once-daily, modified-release formulation of the drug candidate, intended to maintain healthy blood sugar levels and address obesity.Akebia Therapeutics  was up more than 4% after saying it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor.Cara Therapeutics  was more than 10% higher after saying it is exploring and reviewing strategic alternatives, sending shares up by more than 8% in pre-bell activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1883839398.USD","LU0122379950.USD","BK4139","IE00BLSP4452.SGD","BK4581","IE00B19Z3B42.SGD","LU0456855351.SGD","SG9999001176.SGD","SG9999002224.SGD","BK4550","BK4533","AKBA","LU1057294990.SGD","SG9999001176.USD","BK4007","PFE.AU","SGXZ57979304.SGD","SG9999013999.USD","LU1023059063.AUD","LU0234572021.USD","IE00BBT3K403.USD","LU0289739699.SGD","BK7095","BK4534","CARA","LU0321505868.SGD","LU1894683264.USD","BK4568","SG9999003800.SGD","SG9999002232.USD","LU0170899867.USD","XLV","PFE","BK4585","IBB","BK4592","LU1066053197.SGD","IE00BLSP4239.USD","LU0321505439.SGD","LU1066051498.USD","IE0002270589.USD","LU0058720904.USD","LU0868494617.USD","SG9999011175.SGD","LU1894683348.USD","BK4588","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2450550403","title":"Cara Therapeutics Explores Strategic Alternatives; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2450550403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450550403?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:46","pubTimestamp":1720698370,"startTime":"0","endTime":"0","summary":"Cara Therapeutics  said Thursday it is exploring and reviewing strategic alternatives, sending shares up by more than 8% in pre-bell activity.The company said it has engaged Piper Sandler & Co. as its financial adviser for the process but declined to disclose further details until the board approves them.As of March 31, the company had about $70 million in cash, cash equivalents and marketable securities.Price: 0.31, Change: +0.024, Percent Change: +8.39","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CARA"],"gpt_icon":0},{"id":"2450356866","title":"Cara Therapeutics Explores Strategic Alternatives; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2450356866","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450356866?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:46","pubTimestamp":1720698370,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["CARA","BK4007"],"gpt_icon":0},{"id":"2450419353","title":"BRIEF-Cara Therapeutics Announces Exploration Of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2450419353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450419353?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:25","pubTimestamp":1720697137,"startTime":"0","endTime":"0","summary":"July 11 (Reuters) - Cara Therapeutics Inc   :   * CARA THERAPEUTICS ANNOUNCES EXPLORATION OF STRATEGIC ALTERNATIVES   * CARA THERAPEUTICS INC - ENGAGES PIPER SANDLER AS FINANCIAL ADVISORSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA"],"gpt_icon":0},{"id":"2450454330","title":"Cara Therapeutics Announces Exploration of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2450454330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450454330?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:00","pubTimestamp":1720695600,"startTime":"0","endTime":"0","summary":"Cara Therapeutics Announces Exploration of Strategic Alternatives","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nTUA3KHZGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CARA"],"gpt_icon":0},{"id":"2450300683","title":"Cara Therapeutics Inc - Engages Piper Sandler as Financial Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2450300683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450300683?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:00","pubTimestamp":1720695600,"startTime":"0","endTime":"0","summary":"Cara Therapeutics Inc - Engages Piper Sandler as Financial Advisor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nTUA3KHZGW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CARA"],"gpt_icon":0},{"id":"2450330047","title":"Cara Therapeutics Announces Exploration of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2450330047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450330047?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:00","pubTimestamp":1720695600,"startTime":"0","endTime":"0","summary":"Piper Sandler & Co. to act as financial advisorSTAMFORD, Conn., July  11, 2024  (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc.(Nasdaq: CARA) today announced that it has engaged Piper Sandler & Co. to act","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/11/2911690/29236/en/Cara-Therapeutics-Announces-Exploration-of-Strategic-Alternatives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA"],"gpt_icon":0},{"id":"2445014346","title":"Carasent To Supply Ad Curis To Frelsesarmeen","url":"https://stock-news.laohu8.com/highlight/detail?id=2445014346","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2445014346?lang=en_us&edition=fundamental","pubTime":"2024-06-24 13:02","pubTimestamp":1719205376,"startTime":"0","endTime":"0","summary":"Carasent ASA :Carasent Group Signs Contract To Supply Ad Curis To Frelsesarmeen.Annual Recurring Revenue From Contract Is Nok 3.3 Million.Contract Also Includes Nok 6 Million Of Consulting Revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARA","CRIS","BK4139","BK4007"],"gpt_icon":0},{"id":"2444211912","title":"Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2444211912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444211912?lang=en_us&edition=fundamental","pubTime":"2024-06-20 21:14","pubTimestamp":1718889297,"startTime":"0","endTime":"0","summary":"Health care stocks were lower pre-bell Thursday as the Health Care Select Sector SPDR Fund  was down 0.3% and iShares Biotechnology ETF  was recently declining by 0.3%. Jazz Pharmaceuticals  was down more than 3% after saying its investigational therapy suvecaltamide did not meet its primary endpoint in a phase 2b trial evaluating its efficacy and safety in adult patients with essential tremor.PTC Therapeutics  was up over 3% after saying the US Food and Drug Administration has lifted the partial clinical hold on its PTC518 program following favorable interim results from the phase 2 PIVOT-HD study in Huntington's disease patients.Cara Therapeutics  late Tuesday disclosed plans to explore strategic alternatives and lay off 70% of its workforce after discontinuing work on its difelikefalin drug candidate last week for failing to show clinical benefit in pruritus treatment, a nerve disorder. Cara Therapeutics rose past 8% premarket.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","LU0109394709.USD","BK4585","JAZZ","LU0320765992.SGD","BK4532","BK4581","IBB","BK4588","CARA","PTCT","BK4139","BK4007","BK4533","LU0889565916.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.caratherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.2655},{"period":"3month","weight":-0.0028},{"period":"6month","weight":-0.5679},{"period":"1year","weight":-0.704},{"period":"ytd","weight":-0.5638}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0798},{"period":"6month","weight":0.1279},{"period":"1year","weight":0.3308},{"period":"ytd","weight":0.2564}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.067158},{"month":2,"riseRate":0.363636,"avgChangeRate":0.022695},{"month":3,"riseRate":0.545455,"avgChangeRate":0.01829},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.111103},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.001774},{"month":6,"riseRate":0.636364,"avgChangeRate":-0.002947},{"month":7,"riseRate":0.454545,"avgChangeRate":0.089214},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.002014},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.067808},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.031996},{"month":11,"riseRate":0.636364,"avgChangeRate":0.057625},{"month":12,"riseRate":0.4,"avgChangeRate":-0.091766}],"exchange":"NASDAQ","name":"Cara Therapeutics","nameEN":"Cara Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cara Therapeutics(CARA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cara Therapeutics(CARA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cara Therapeutics,CARA,Cara Therapeutics股票,Cara Therapeutics股票老虎,Cara Therapeutics股票老虎国际,Cara Therapeutics行情,Cara Therapeutics股票行情,Cara Therapeutics股价,Cara Therapeutics股市,Cara Therapeutics股票价格,Cara Therapeutics股票交易,Cara Therapeutics股票购买,Cara Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cara Therapeutics(CARA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cara Therapeutics(CARA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction